Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)

Clinical trial NCT01974752 · COMPLETED

Trial details

NCT number: NCT01974752
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Uveal Melanoma

Start date: 2014-04-01
Primary completion: 2015-05-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.